Fund shareholders of Innovent Biologics Inc
ISIN KYG4818G1010 · Hong Kong SAR China · LEI 25490058ONL9SCIE1R22
- Fund shareholders
- 216
- Of which ETFs
- 59 157 other funds
- Value held
- ≈ 2.1B $ 2.1B $ · 619.4M SEK · 1.3M €
216 funds hold this company. This table lists the 206 that declare it in a regulatory filing. The other 10 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 116.8K € | 0.02 % | as of Dec 31, 2025 ↗ | |
| INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 87.6K € | 0.03 % | as of Dec 31, 2025 ↗ | |
| MICROBANK SI IMPACTO RENTA VARIABLE, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 65.1K € | 0.26 % | as of Dec 31, 2025 ↗ | |
| INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 29.2K € | 0.04 % | as of Dec 31, 2025 ↗ | |
| SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 29.2K € | 0.02 % | as of Dec 31, 2025 ↗ | |
| SABADELL EMERGENTE MIXTO FLEXIBLE, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 16.7K € | 0.04 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Funds - All China Equity ESG Fund FIL Investment Management (Luxembourg) S.A. | 1.96 % | as of Apr 30, 2025 ↗ |
| BNP Paribas Funds China Equity BNP Paribas Asset Management Luxembourg | 1.51 % | as of Dec 31, 2025 ↗ |
| Fidelity Funds - Greater China Fund FIL Investment Management (Luxembourg) S.A. | 1.46 % | as of Apr 30, 2025 ↗ |
| Fidelity Funds - Greater China Fund Ii FIL Investment Management (Luxembourg) S.A. | 1.44 % | as of Apr 30, 2025 ↗ |
| BNP Paribas Funds Asia ex-Japan Equity BNP Paribas Asset Management Luxembourg | 1.09 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Asia Tech Innovators BNP Paribas Asset Management Luxembourg | 1.06 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Emerging Equity BNP Paribas Asset Management Luxembourg | 1.02 % | as of Dec 31, 2025 ↗ |
| Fidelity Funds - Asian Special Situations Fund FIL Investment Management (Luxembourg) S.A. | 0.93 % | as of Apr 30, 2025 ↗ |
| BNP Paribas Funds Global Megatrends BNP Paribas Asset Management Luxembourg | 0.38 % | as of Dec 31, 2025 ↗ |
| BNP Paribas Funds Multi-Asset Opportunities BNP Paribas Asset Management Luxembourg | 0.12 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| KraneShares MSCI All China Health Care Index ETF Krane Shares Trust | 8.80 % | as of Jun 30, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 5.00 % | as of Jun 30, 2026 ↗ |
| Ashmore Emerging Markets Equity SMA Completion Fund Ashmore Funds | 2.47 % | as of Jul 31, 2026 ↗ |
| AMG Veritas China Fund AMG Funds I | 2.46 % | as of Jul 31, 2026 ↗ |
| Roundhill GLP-1 & Weight Loss ETF Roundhill ETF Trust | 2.37 % | as of Jun 30, 2026 ↗ |
| PGIM Jennison Emerging Markets Equity Opportunities Fund Prudential World Fund, Inc. | 2.31 % | as of Jul 31, 2026 ↗ |
| Ashmore Emerging Markets Equity ESG Fund Ashmore Funds | 2.21 % | as of Jul 31, 2026 ↗ |
| Lannebo Global Growth Lannebo Kapitalförvaltning AB | 2.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Funds - All China Equity ESG Fund FIL Investment Management (Luxembourg) S.A. | 1.96 % | as of Apr 30, 2025 ↗ |
| Matthews China Fund Matthews International Funds | 1.74 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 174 | +9 | 191,398,754 | +12.8 % |
| 2026Q2 | 165 | +6 | 169,698,110 | +4.2 % |
| 2026Q1 | 159 | -1 | 162,919,417 | +3.6 % |
| 2025Q4 | 160 | +19 | 157,269,863 | +4.0 % |
| 2025Q3 | 141 | +11 | 151,203,725 | -9.0 % |
| 2025Q2 | 130 | 0 | 166,149,471 | -10.1 % |
| 2025Q1 | 130 | -25 | 184,889,222 | -12.3 % |
| 2024Q4 | 155 | +5 | 210,880,151 | +0.1 % |
| 2024Q3 | 150 | +5 | 210,727,134 | -2.9 % |
| 2024Q2 | 145 | +15 | 216,986,691 | +35.3 % |
| 2024Q1 | 130 | +2 | 160,422,875 | -16.6 % |
| 2023Q4 | 128 | 192,325,191 |
Cite this page
Titelia. "Fund shareholders of Innovent Biologics Inc". https://titelia.com/en/stocks/innovent-biologics-inc-KYG4818G1010